Evidence map›Paper›PMID 24859390›Full record

ArticleEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2014

Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface.

Dilip Devineni, Christoph Gonschorek, Marcus T Cicerone, Yemin Xu, John F Carpenter, Theodore W Randolph

Open access · greenAbstract read
In one paragraph

Article in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Stable Dried Catalase Particles Prepared by Electrospraying.Nanomaterials (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Silk-based stabilization of biomacromolecules.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  5. Stabilization of proteins in solid form.Advanced drug delivery reviews · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Dilip DevineniDepartment of Pharmaceutical Sciences, University of Colorado, Denver, CO, USA.
Christoph GonschorekSchool of Pharmacy, Ludwig-Maximilians-University, Munich, Germany.
Marcus T CiceronePolymers Division, National Institute of Standards and Technology, Gaithersburg, MD, USA.
Yemin XuDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO, USA.
John F CarpenterDepartment of Pharmaceutical Sciences, University of Colorado, Denver, CO, USA.
Theodore W RandolphDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO, USA. Electronic address: theodore.randolph@colorado.edu.
University of Colorado Denver · USLudwig-Maximilians-Universität München · DENational Institute of Standards and Technology · USUniversity of Colorado Boulder · US

Funding

Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic ProteinsR01EB006006 · NIBIB · UNIVERSITY OF COLORADO · PI RANDOLPH, THEODORE W · 2006 to 2017
$7.2M
NIBIB NIH HHS R01 EB006006
6 · The paper itself

Abstract

Lyophilized formulations of keratinocyte growth factor-2 (KGF-2) were prepared with a range of disaccharide (sucrose or trehalose) and hydroxyethyl starch (HES) mass ratios. Protein degradation was assessed as a function of time of storage of the dried formulations at 40, 50 and 60°C. Lyophilized and stored samples were rehydrated, and protein degradation was quantified by measuring loss of monomeric protein with size exclusion chromatography and by determining chemical degradation in the soluble fraction with reverse-phase chromatography. The secondary structure of the protein in the lyophilized formulations was studied with infrared spectroscopy. The magnitudes of degradation were compared the key physical properties of the formulations including retention of protein native secondary structure, glass transition temperature (Tg), inverse mean square displacements 〈u(2)〉(-1) for hydrogen atoms (fast β relaxation), and the relaxation time τ(β), which correlates with relaxation due to fast Johari-Goldstein motions in the glass (Xu et al., 2013) [1]. In addition, specific surface areas of the lyophilized formulations were determined by Brunauer-Emmet-Teller analysis of krypton adsorption isotherms and used to estimate the fraction of the KGF-2 molecules residing at the solid-air interface. KGF-2 degradation rates were highest in formulations wherein the protein's structure was most perturbed, and wherein β relaxations were fastest, but the dominant factor governing KGF-2 degradation in freeze-dried formulations was the fraction of the protein found at the glass solid-air interface.

Indexed as

Chemistry, PharmaceuticalAirFibroblast Growth Factor 10Freeze DryingGlassHumansOxidation-ReductionProtein Structure, SecondarySurface PropertiesFibroblast Growth Factor 10Glass dynamicsGlass transition temperatureGlobal mobilityKGF-2Local mobilityLyophilizationProtein interfacial adsorptionProtein stabilityProtein structureStructural relaxation time

Identifiers

PMID24859390
PMCPMC4240752
OpenAlexW2069701590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.